Cardiac tamponade from metastatic urothelial carcinoma
DOI:
https://doi.org/10.37615/retic.v8n3a12Keywords:
cardiac tamponade, pericardial effusion due to metastasis, cardiac tamponade due to urothelial cancerAbstract
We present an uncommon case of cardiac tamponade caused by metastasis from urothelial carcinoma. Pericardiocentesis provided immediate relief, and pathological analysis confirmed the suspicion. The definitive treatment is that of the underlying pathology with immunotherapy or systemic chemotherapy.
Downloads
Metrics
References
Palam S, Kapoor R, Kulinski J. A Rare Presentation of Cardiac Tamponade from Metastatic Urothelial Carcinoma of the Bladder. Case Rep Cardiol. 2018 Jun 19;2018:6750264. Erratum in: Case Rep Cardiol. 2019 Sep 12; 2019:8376360. doi: https://doi.org/10.1155/2018/6750264 DOI: https://doi.org/10.1155/2018/6750264
Palacka P, Janega P, Polakova H, Slopovsky J, De Angelis V, Mego M. Pericardial malignant infiltration as the cause of sudden death of a patient with metastatic urothelial carcinoma treated with atezolizumab. BMC Urol 2022 Jul 18;22(1):108. doi: https://doi.org/10.1186/s12894-022-01064-x DOI: https://doi.org/10.1186/s12894-022-01064-x
Bussani R, De-Giorgio F, Abbate A, Silvestri F. Cardiac metastases J Clin Pathol 2007;60(1):27-34. doi: https://doi.org/10.1136/jcp.2005.035105 DOI: https://doi.org/10.1136/jcp.2005.035105
Wan Muhamad Hatta SS, Mirza AR, Sunni N, Bashir A. Heart-breaking tumours: a case series of malignant pericardial effusion. Eur Heart J Case Rep 2025 Jan 18;9(3):ytaf009. doi: https://doi.org/10.1093/ehjcr/ytaf009 DOI: https://doi.org/10.1093/ehjcr/ytaf009
Rooper LM, Ali SZ, Olson MT. A Minimum Volume of More Than 60 mL Is Necessary for Adequate Cytologic Diagnosis of Malignant Pericardial Effusions. Am J Clin Pathol 2016 Jan;145(1):101-6. doi: https://doi.org/10.1093/ajcp/aqv021 DOI: https://doi.org/10.1093/ajcp/aqv021
Saab J, Hoda RS, Narula N, Hoda SA, Geraghty BE, Nasar A, et al. Diagnostic yield of cytopathology in evaluating pericardial effusions: Clinicopathologic analysis of 419 specimens. Cancer Cytopathol 2017 Feb;125(2):128-137. doi: https://doi.org/10.1002/cncy.21790 DOI: https://doi.org/10.1002/cncy.21790
Powles T, Park SH, Voog E, Caserta C, Valderrama BP, Gurney H, et al. Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma. N Engl J Med 2020 Sep 24;383(13):1218-1230. doi: https://doi.org/10.1056/NEJMoa2002788 DOI: https://doi.org/10.1056/NEJMoa2002788
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Antonio Jalón Monzón, Daniel García Tejero, Ricardo Alguero Menéndez
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
RETIC is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license https://creativecommons.org/licenses/by-nc-nd/4.0 which allows sharing, copying and redistribution of the material in any medium or format, under the following terms:
- Attribution: you must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests that the licensor endorses you or your use.
- Non-commercial: you may not use the material for commercial purposes.
- No Derivatives: if you remix, transform or build upon the material, you may not distribute the modified material.
- No Additional Restrictions: you may not apply legal terms or technological measures that legally restrict others from doing anything permitted by the license.
